GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Caliway Biopharmaceuticals Co Ltd (ROCO:6919) » Definitions » PB Ratio

Caliway Biopharmaceuticals Co (ROCO:6919) PB Ratio : 9.24 (As of Jun. 20, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Caliway Biopharmaceuticals Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-20), Caliway Biopharmaceuticals Co's share price is NT$496.50. Caliway Biopharmaceuticals Co's Book Value per Share for the quarter that ended in Dec. 2023 was NT$53.71. Hence, Caliway Biopharmaceuticals Co's PB Ratio of today is 9.24.

The historical rank and industry rank for Caliway Biopharmaceuticals Co's PB Ratio or its related term are showing as below:

ROCO:6919' s PB Ratio Range Over the Past 10 Years
Min: 4.8   Med: 13.85   Max: 23.97
Current: 9.24

During the past 5 years, Caliway Biopharmaceuticals Co's highest PB Ratio was 23.97. The lowest was 4.80. And the median was 13.85.

ROCO:6919's PB Ratio is ranked worse than
88.93% of 1301 companies
in the Biotechnology industry
Industry Median: 2.35 vs ROCO:6919: 9.24

During the past 12 months, Caliway Biopharmaceuticals Co's average Book Value Per Share Growth Rate was 184.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 294.80% per year.

During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Caliway Biopharmaceuticals Co was 294.80% per year. The lowest was 294.80% per year. And the median was 294.80% per year.

Back to Basics: PB Ratio


Caliway Biopharmaceuticals Co PB Ratio Historical Data

The historical data trend for Caliway Biopharmaceuticals Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caliway Biopharmaceuticals Co PB Ratio Chart

Caliway Biopharmaceuticals Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
- - - 6.48 7.18

Caliway Biopharmaceuticals Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial - - 6.48 23.55 7.18

Competitive Comparison of Caliway Biopharmaceuticals Co's PB Ratio

For the Biotechnology subindustry, Caliway Biopharmaceuticals Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caliway Biopharmaceuticals Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Caliway Biopharmaceuticals Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Caliway Biopharmaceuticals Co's PB Ratio falls into.



Caliway Biopharmaceuticals Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Caliway Biopharmaceuticals Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=496.50/53.711
=9.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Caliway Biopharmaceuticals Co  (ROCO:6919) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Caliway Biopharmaceuticals Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Caliway Biopharmaceuticals Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Caliway Biopharmaceuticals Co (ROCO:6919) Business Description

Traded in Other Exchanges
N/A
Address
No.99, Sec. 1, Xintai 5th Road, 32F.-9, Xizhi District, New Taipei City, TWN, 221
Caliway Biopharmaceuticals Co Ltd is specialized in the development of new drugs for medical aesthetic and inflammatory diseases. Its leading candidate, CBL-514, is a new drug that can trigger adipocyte apoptosis at the injection site and effectively reduce subcutaneous fat without causing tissue necrosis or prominent side effects.

Caliway Biopharmaceuticals Co (ROCO:6919) Headlines

No Headlines